Gene · 3735
Papers1,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers. | Front Genet | 2022 | 36685853 | PubTator, text mining | PubMed |
| Prion Mutations in Republic of Republic of Korea, China, and Japan. | Int J Mol Sci | 2022 | 36614069 | PubTator, text mining | PubMed |
| Corroboration of cross-reactivity between Mycobacterium leprae and hosts' salivary and cutaneous proteins: A hope for prognostic biomarkers for the pathogenesis of reactions in leprosy. | Front Microbiol | 2022 | 36560940 | PubTator, text mining | PubMed |
| The Role of Nuclear-Encoded Mitochondrial tRNA Charging Enzymes in Human Inherited Disease. | Genes (Basel) | 2022 | 36553587 | PubTator, text mining | PubMed |
Prenatal Identification of a Novel Mutation in the MCPH1 Gene Associated with Autosomal Recessive Primary Microcephaly (MCPH) Using Next Generation Sequencing (NGS): A Case Report and Review of the Literature. | Children (Basel) | 2022 | 36553323 | PubTator, text mining | PubMed |
| Native holdup (nHU) to measure binding affinities from cell extracts. | Sci Adv | 2022 | 36542723 | PubTator, text mining | PubMed |
| The progress and challenges of circRNA for diabetic foot ulcers: A mini-review. | Front Endocrinol (Lausanne) | 2022 | 36531481 | PubTator, text mining | PubMed |
| Bilateral Nonsyndromic Sensorineural Hearing Loss Caused by a NARS2 Mutation. | Cureus | 2022 | 36523694 | PubTator, text mining | PubMed |
| An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy. | Front Immunol | 2022 | 36505399 | PubTator, text mining | PubMed |
| RNA granule-clustered mitochondrial aminoacyl-tRNA synthetases form multiple complexes with the potential to fine-tune tRNA aminoacylation. | Nucleic Acids Res | 2022 | 36503967 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction and Oxidative Stress in Hereditary Ectopic Calcification Diseases. | Int J Mol Sci | 2022 | 36499615 | PubTator, text mining | PubMed |
| Loneliness, Depression, and Genetics in the Elderly: Prognostic Factors of a Worse Health Condition? | Int J Environ Res Public Health | 2022 | 36497531 | PubTator, text mining | PubMed |
| Identification of a differential metabolite-based signature in patients with late-stage knee osteoarthritis. | Osteoarthr Cartil Open | 2022 | 36474953 | PubTator, text mining | PubMed |
| mRNA 5' terminal sequences drive 200-fold differences in expression through effects on synthesis, translation and decay. | PLoS Genet | 2022 | 36441824 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling of colorectal cancer patients reveals differences in mutational landscapes among clinical and pathological subgroups. | Front Oncol | 2022 | 36439454 | PubTator, text mining | PubMed |
| Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia? | Cancers (Basel) | 2022 | 36428753 | PubTator, text mining | PubMed |
| Metabolomic Profiling, In Vitro Antimalarial Investigation and In Silico Modeling of the Marine Actinobacterium Strain Rhodococcus sp. UR111 Associated with the Soft Coral Nephthea sp. | Antibiotics (Basel) | 2022 | 36421275 | PubTator, text mining | PubMed |
| Identification of a novel cell cycle-related risk signature predicting prognosis in patients with pancreatic adenocarcinoma. | Medicine (Baltimore) | 2022 | 36401386 | PubTator, text mining | PubMed |
Dynamic Long-Range Interactions Influence Substrate Binding and Catalysis by Human Histidine Triad Nucleotide-Binding Proteins (HINTs), Key Regulators of Multiple Cellular Processes and Activators of Antiviral ProTides. | Biochemistry | 2022 | 36398895 | PubTator, text mining | PubMed |
| Integrin subunit alpha V is a potent prognostic biomarker associated with immune infiltration in lower-grade glioma. | Front Neurol | 2022 | 36388191 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3735/papers?page=11